Schedule 1 Barriers to Research in the UK: An In-depth Qualitative Analysis

Authors Annie Howard, Joanna C Neill, Anne Katrin Schlag, Charlotte Lennox Published October 25, 2021 Prior to the 1970s, psychedelics such as LSD were used and researched extensively. However, with the introduction of the UN convention Misuse of Drugs Regulations in 2001, all drugs were placed into one of five categories or ‘schedules’ based on  …


Launch of the Medical Psychedelics Working Group

On Tuesday July 14th, 2020, Drug Science will launch a new working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes. However, current UK regulations have created serious and considerable barriers to legitimate research associated with Schedule 1 regulations.  …

Cannabis Review for the attention of the WHO

Read the full report The scheduling under the Single Convention on Narcotic Drugs assumes a scientific justification. However, cannabis and cannabis resin have never been evaluated by the World Health Organisation (WHO) since it was mandated the review of psychoactive substances in 1948. The last evaluation for the international substance control conventions were therefore when  …